These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Extended International Normalized Ratio testing intervals for warfarin-treated patients. Barnes GD; Kong X; Cole D; Haymart B; Kline-Rogers E; Almany S; Dahu M; Ekola M; Kaatz S; Kozlowski J; Froehlich JB J Thromb Haemost; 2018 Jul; 16(7):1307-1312. PubMed ID: 29763979 [TBL] [Abstract][Full Text] [Related]
4. Optimal INR level for warfarin therapy after mechanical mitral valve replacement. Kamthornthanakarn I; Krittayaphong R BMC Cardiovasc Disord; 2019 Apr; 19(1):97. PubMed ID: 31023235 [TBL] [Abstract][Full Text] [Related]
5. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records. Menzin J; Hoesche J; Friedman M; Nichols C; Bergman GE; Crowther M; Garcia D; Jones C J Thromb Haemost; 2012 Apr; 10(4):596-605. PubMed ID: 22257107 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty. Lieberman JR; Wollaeger J; Dorey F; Thomas BJ; Kilgus DJ; Grecula MJ; Finerman GA; Amstutz HC J Bone Joint Surg Am; 1997 Mar; 79(3):319-25. PubMed ID: 9070518 [TBL] [Abstract][Full Text] [Related]
8. Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy. Smith KR; Bryan WE; Townsend ML; Randolph AE; Vanderman AJ; Woodard CL; Brown JN J Thromb Thrombolysis; 2020 Aug; 50(2):452-456. PubMed ID: 31898274 [TBL] [Abstract][Full Text] [Related]
9. Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users. Witt DM; Delate T; Clark NP; Martell C; Tran T; Crowther MA; Garcia DA; Ageno W; Hylek EM; J Thromb Haemost; 2010 Apr; 8(4):744-9. PubMed ID: 20398186 [TBL] [Abstract][Full Text] [Related]
10. Effect of oral diuretics on chronic warfarin therapy: a retrospective study. Edwards HD; Webb RD; Conway SE Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964 [TBL] [Abstract][Full Text] [Related]
11. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery. Meijer K; Kim YK; Carter D; Schulman S Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999 [TBL] [Abstract][Full Text] [Related]
12. Feasibility and safety of a 12-week INR follow-up protocol over 2 years in an anticoagulation clinic: a single-arm prospective cohort study. Porter AL; Margolis AR; Staresinic CE; Nagy MW; Schoen RR; Ray CA; Fletcher CD J Thromb Thrombolysis; 2019 Feb; 47(2):200-208. PubMed ID: 30368762 [TBL] [Abstract][Full Text] [Related]
13. Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation. Gautam S; John RM; Stevenson WG; Jain R; Epstein LM; Tedrow U; Koplan BA; McClennen S; Michaud GF J Cardiovasc Electrophysiol; 2011 Mar; 22(3):248-54. PubMed ID: 20812929 [TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial. Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U; J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Retrievable Inferior Vena Cava Filter Placement in the Prevention of Pulmonary Embolism during Catheter-Directed Thrombectomy for Proximal Lower-Extremity Deep Vein Thrombosis. Lee SH; Kim HK; Hwang JK; Kim SD; Park SC; Kim JI; Won YS; Youn SS; Moon IS Ann Vasc Surg; 2016 May; 33():181-6. PubMed ID: 26806235 [TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin. Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136 [TBL] [Abstract][Full Text] [Related]
17. Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation. Kang F; Ma Y; Cai A; Cheng X; Liu P; Kuang J; Mai Z; Mai W Am J Cardiol; 2021 Mar; 142():74-82. PubMed ID: 33307015 [TBL] [Abstract][Full Text] [Related]
18. A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism. Amiwero C; Campbell IA; Prescott RJ Afr Health Sci; 2009 Sep; 9(3):179-85. PubMed ID: 20589148 [TBL] [Abstract][Full Text] [Related]
19. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention. Hirano T; Kaneko H; Mishina S; Wang F; Morita S J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651 [TBL] [Abstract][Full Text] [Related]
20. Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism. Nordstrom BL; Kachroo S; Fraeman KH; Nutescu EA; Schein JR; Fisher A; Bookhart BK Curr Med Res Opin; 2011 Oct; 27(10):1973-85. PubMed ID: 21919556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]